Voafinidine is primarily used in the development of pharmaceutical agents targeting central nervous system disorders. It serves as a key intermediate in synthesizing compounds with potential antidepressant and anxiolytic effects. Its molecular structure allows for selective interaction with neurotransmitter receptors, particularly those involved in mood regulation, making it valuable in early-stage drug discovery. Researchers also explore its derivatives for improving cognitive function and treating neurodegenerative conditions. Due to its stability and reactivity profile, it is suitable for scalable synthesis in medicinal chemistry workflows.